A Study of GC007F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

NCT03825718 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

B-cell Acute Lymphoblastic Leukemia

Interventions

BIOLOGICAL: GC007F

Sponsor

Hebei Yanda Ludaopei Hospital

Collaborators

[object Object]